Technology

Vascular Biogenics

$2.88
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (+5.08%) Today
+$0.19 (+7.06%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VBLT and other stocks, options, and ETFs commission-free!

About VBLT

Vascular Biogenics Ltd. Ordinary Shares, also called Vascular Biogenics, is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. The listed name for VBLT is Vascular Biogenics Ltd. Ordinary Shares.

CEO
Dror Harats
Employees
—
Headquarters
Modi’in, Jerusalem
Founded
2000
Market Cap
126.59M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
675.81K
High Today
$3.09
Low Today
$2.56
Open Price
$2.69
Volume
3.44M
52 Week High
$3.09
52 Week Low
$0.90

Collections

VBLT Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 18, Pre-Market

You May Also Like

AWRE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure